EX-23.2 8 a2017-10kxexhibit232consen.htm EXHIBIT 23.2 CONSENT OF BDO Exhibit

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

Cumberland Pharmaceuticals Inc.
Nashville, Tennessee

We hereby consent to the incorporation by reference in the Registration Statements on Form S­-3 (No. 333-221402) and Form S-8 (No. 333-164376) of Cumberland Pharmaceuticals Inc. of our report dated March 9, 2018, relating to the consolidated financial statements and financial statement schedule which appears in this Form 10-K.


Nashville, Tennessee
March 9, 2018